Human Metabolome Technologies (TSE:6090) Other Current Payables: 円25 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6090 Human Metabolome Technologies Inc TSE:6090
62 GF Score
Price 円623.00
GF Value 円695.16
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Human Metabolome Technologies Other Current Payables?

Human Metabolome Technologies TSE:6090 +1.47% 62 Other Current Payables is 円25 Mil as of Mar. 2026. GuruFocus rates TSE:6090 with a GF Score™ of 62/100 and a GF Value™ of 円695.16 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Human Metabolome Technologies's Other Current Payables for the quarter that ended in Mar. 2026 was 円25 Mil.

Human Metabolome Technologies's quarterly Other Current Payables declined from Sep. 2025 (円38 Mil) to Dec. 2025 (円33 Mil) and declined from Dec. 2025 (円33 Mil) to Mar. 2026 (円25 Mil).

Human Metabolome Technologies's annual Other Current Payables increased from Jun. 2023 (円79 Mil) to Jun. 2024 (円188 Mil) but then declined from Jun. 2024 (円188 Mil) to Jun. 2025 (円98 Mil).

Human Metabolome Technologies Other Current Payables Related Terms

Human Metabolome Technologies Other Current Payables Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies Other Current Payables Chart

Human Metabolome Technologies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.44 128.68 78.81 187.91 97.80

Human Metabolome Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.80 37.73 33.34 25.19 117.62
TSE:6090
62GF Score
Human Metabolome Technologies Inc TSE:6090
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Human Metabolome Technologies Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of 円25 Mil mean?
Human Metabolome Technologies (TSE:6090) has a Other Current Payables of 円25 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Human Metabolome Technologies and its competitors.
Is Human Metabolome Technologies' Other Current Payables too high?
Human Metabolome Technologies' current Other Current Payables is 円25 Mil. Overall, Human Metabolome Technologies has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Human Metabolome Technologies' Other Current Payables compare to TMO and DHR?
Human Metabolome Technologies' Other Current Payables of 円25 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Diagnostics & Research company?
A good Other Current Payables depends on the Medical Diagnostics & Research industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current Other Current Payables is 円25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Metabolome Technologies stock overvalued right now?
Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Undervalued. The stock's GF Value™ is 円695.16, compared to a current price of 円623.00 — trading 10.4% below its estimated fair value. The current Other Current Payables is 円25 Mil. Human Metabolome Technologies' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Other Current Payables is 円25 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be undervalued. The current stock price of 円623.00 is trading 10.4% below its estimated GF Value™ of 円695.16. GuruFocus considers Human Metabolome Technologies to be Modestly Undervalued.

Key valuation signals for TSE:6090:

  • Other Current Payables: 円25 Mil
  • GF Value™: 円695.16 vs. price of 円623.00 (10.4% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Human Metabolome Technologies Business Description

Address Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.
62GF Score

Get the complete analysis for TSE:6090

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円623.00
Price
円695.16
GF Value